4,5-Dihydroxypyrimidine Methyl Carboxylates, Carboxylic Acids, and Carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease

J Med Chem. 2022 Apr 14;65(7):5830-5849. doi: 10.1021/acs.jmedchem.2c00203. Epub 2022 Apr 4.

Abstract

Human cytomegalovirus (HCMV) terminase complex entails a metal-dependent endonuclease at the C-terminus of pUL89 (pUL89-C). We report herein the design, synthesis, and characterization of dihydroxypyrimidine (DHP) acid (14), methyl ester (13), and amide (15) subtypes as inhibitors of HCMV pUL89-C. All analogs synthesized were tested in an endonuclease assay and a thermal shift assay (TSA) and subjected to molecular docking to predict binding affinity. Although analogs inhibiting pUL89-C in the sub-μM range were identified from all three subtypes, acids (14) showed better overall potency, substantially larger thermal shift, and considerably better docking scores than esters (13) and amides (15). In the cell-based antiviral assay, six analogs inhibited HCMV with moderate activities (EC50 = 14.4-22.8 μM). The acid subtype (14) showed good in vitro ADME properties, except for poor permeability. Overall, our data support the DHP acid subtype (14) as a valuable scaffold for developing antivirals targeting HCMV pUL89-C.

MeSH terms

  • Amides / chemistry
  • Antiviral Agents* / chemistry
  • Antiviral Agents* / pharmacology
  • Carboxylic Acids / chemistry
  • Cytomegalovirus* / metabolism
  • Endonucleases* / metabolism
  • Humans
  • Molecular Docking Simulation
  • Pyrimidines / chemistry
  • Viral Proteins* / antagonists & inhibitors
  • Viral Proteins* / metabolism

Substances

  • Amides
  • Antiviral Agents
  • Carboxylic Acids
  • Pyrimidines
  • UL89 protein, Cytomegalovirus
  • Viral Proteins
  • Endonucleases